No profile data available.
Oaktree Acquisition Corp. III Life Sciences (OACC) is a financial services company in the acquisition vehicle corporations industry, based in Los Angeles, United States.
It reported revenue of $0 for fiscal year 2025, and net income of $7.29 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $264.26 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
Oaktree Acquisition Corp. III Life Sciences reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$264.26 million as of October 9, 2026.
Listed companies of a similar size in the same industry (acquisition vehicle corporations) include Thayer Ventures Acquisition Corporation II (TVAI), Pyrophyte Acquisition Corp. II (PAII-UN), Cantor Equity Partners I, Inc. (CEPO), Drugs Made In America Acquisition Corp. (DMAA).